CLEVELAND BIOLABS INC - COM NEW (CBLI)

CUSIP: 185860202

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM NEW
Total 13F shares
166,837
Share change
-20,506
Total reported value
$713,000
Price per share
$4.31
Number of holders
9
Value change
-$90,001
Number of buys
4
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 185860202?
CUSIP 185860202 identifies CBLI - CLEVELAND BIOLABS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLEVELAND BIOLABS INC - COM NEW (CBLI) as of Q3 2015

As of 30 Sep 2015, CLEVELAND BIOLABS INC - COM NEW (CBLI) was held by 9 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 166,837 shares. The largest 9 holders included VANGUARD GROUP INC, LADENBURG THALMANN FINANCIAL SERVICES INC, GEODE CAPITAL MANAGEMENT, LLC, KCG Holdings, Inc., MORGAN STANLEY, BlackRock Advisors LLC, THOMPSON DAVIS & CO., INC., Winfield Associates, Inc., and WELLS FARGO & COMPANY/MN. This page lists 9 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.